BREAKING
BioNTech SE (BNTX) Reports Q4 Earnings 9 minutes ago Apyx Medical Corporation (APYX) Reports Q4 Earnings 18 minutes ago Legend Biotech (LEGN) Turns Profitable With $0.01 EPS on 64% Revenue Surge to $306.3M in Q4 24 minutes ago ABM Industries Inc (ABM) Misses Q1 EPS Estimates 30 minutes ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 39 minutes ago Priority Technology Holdings, Inc (PRTH) Reports Q4 Earnings 50 minutes ago Q32 Bio Inc. (QTTB) Reports Q4 Earnings 56 minutes ago BioNTech (BNTX) Posts Q4 Loss of $-1.25/Share as Revenue Falls 23.8% YoY to $907.4M 1 hour ago Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year 1 hour ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 1 hour ago BioNTech SE (BNTX) Reports Q4 Earnings 9 minutes ago Apyx Medical Corporation (APYX) Reports Q4 Earnings 18 minutes ago Legend Biotech (LEGN) Turns Profitable With $0.01 EPS on 64% Revenue Surge to $306.3M in Q4 24 minutes ago ABM Industries Inc (ABM) Misses Q1 EPS Estimates 30 minutes ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 39 minutes ago Priority Technology Holdings, Inc (PRTH) Reports Q4 Earnings 50 minutes ago Q32 Bio Inc. (QTTB) Reports Q4 Earnings 56 minutes ago BioNTech (BNTX) Posts Q4 Loss of $-1.25/Share as Revenue Falls 23.8% YoY to $907.4M 1 hour ago Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year 1 hour ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 1 hour ago
ADVERTISEMENT
Analysis

SGI Shares Slide After Somnigroup Q4 2025 Revenue Beat but Stock Weakens

$SGI February 17, 2026 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results
NYSE
$SGI · Earnings

Somnigroup International Inc.

Somnigroup International Inc. (NYSE: SGI) shares declined sharply following the company’s release of fourth-quarter and full-year 2025 financial results. At the latest US market close, SGI was trading near $90.14, down approximately 1.0% on the day, according to exchange data showing a session range from about $90.10 to $91.49.

Market Capitalization

Based on the most recent closing price, Somnigroup’s market capitalization was approximately $20.2 billion, reflecting shares outstanding.

Latest Quarterly Results

For the quarter ended December 31, 2025, Somnigroup reported total consolidated net sales of $1,868.4 million, up from $1,207.9 million in the prior-year period, representing a 54.7% increase. Net income was $140.8 million, compared with $71.9 million in the fourth quarter of 2024, an increase of 95.8%. Diluted earnings per share were $0.66, up from $0.40, and adjusted EPS was $0.72, compared with $0.60 a year earlier.

Full-Year Results Context

For the 2025 fiscal year, Somnigroup reported net sales of $7,476.5 million, up from $4,930.9 million in 2024, indicating 51.6% annual growth. Net income for the full year was $384.1 million, compared with $384.3 million a year earlier, showing a slight year-over-year contraction. Adjusted net income rose to $565.3 million from $455.1 million, up about 24.2%. Full-year EPS was $1.84, versus $2.16 in 2024; adjusted EPS was $2.70, up from $2.55.

Business & Operations Update

Somnigroup’s reported results reflected the full-year contribution of its acquisition of Mattress Firm, completed in early 2025, which accounted for a significant portion of quarterly sales and direct-to-consumer net sales. Segment disclosures showed direct-to-consumer sales increasing as a share of total net sales, and operating income growth across core businesses.

ADVERTISEMENT

M&A or Strategic Moves

Late in 2025, Somnigroup submitted a non-binding all-stock acquisition proposal to acquire Leggett & Platt Inc., subject to due diligence and board review by the target, though no definitive agreement was reached by year-end.

Equity Analyst Commentary

Market commentary noted that SGI’s reported revenue for Q4 2025 fell short of certain analyst forecasts, contributing to downward pressure on the stock following the earnings announcement. Analysts highlighted the company’s EPS performance aligning with expectations while revenue came in below some market estimates.

Guidance & Outlook

Somnigroup reiterated expectations for 2026 adjusted EPS in the range of approximately $3.00 to $3.40. Company disclosures also highlighted industry demand conditions and operational synergies as key areas for monitoring in the year ahead.

Performance Summary

SGI shares declined after the earnings release. Fourth-quarter consolidated net sales and net income increased sharply year-over-year. Full-year revenue expanded, while net income was largely stable. Strategic actions continued with acquisition discussions. Agents will watch 2026 adjusted EPS guidance and integration progress.

ADVERTISEMENT